Céline Colin
Merck & Co., Inc., Rahway, NJ, USA (United States)(US)Institut national de recherche en sciences et technologies du numérique(FR)Université de Bordeaux(FR)Inserm(FR)Centre Hospitalier Universitaire de Bordeaux(FR)Bordeaux Population Health(FR)Institut Bergonié(FR)Centre d'Investigation Clinique Plurithématique de Bordeaux
Publications by Year
Research Areas
HIV Research and Treatment, HIV/AIDS drug development and treatment, HIV/AIDS Research and Interventions, HIV-related health complications and treatments, Viral Infections and Outbreaks Research
Most-Cited Works
- → Effect of transmitted drug resistance on virological and immunological response to initial combination antiretroviral therapy for HIV (EuroCoord-CHAIN joint project): a European multicohort study(2011)384 cited
- → High Rate of Virologic Suppression with Raltegravir plus Etravirine and Darunavir/Ritonavir among Treatment‐Experienced Patients Infected with Multidrug‐Resistant HIV: Results of the ANRS 139 TRIO Trial(2009)237 cited
- → Risk of triple-class virological failure in children with HIV: a retrospective cohort study(2011)116 cited
- → The Incidence of AIDS-Defining Illnesses at a Current CD4 Count ≥200 Cells/µL in the Post–Combination Antiretroviral Therapy Era(2013)106 cited
- → Safety and immunogenicity of the live attenuated intranasal pertussis vaccine BPZE1: a phase 1b, double-blind, randomised, placebo-controlled dose-escalation study(2020)54 cited
- → Stimulation of the primary anti-HIV antibody response by IFN-α in patients with acute HIV-1 infection